171 www.iakardiologie.cz / Interv Akut Kardiol. 2023;22(4):166-172 / INTERVENČNÍ A AKUTNÍ KARDIOLOGIE PŘEHLEDOVÉ ČLÁNKY / REVIEW ARTICLES Současný pohled na indikace CTO PCI gioplasty for total coronary artery occlussion: an analysis of 971 lesions in 905 patients. J Am Coll Cardiol. 1990;15:849-56. 4. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long‑term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38:409-14. 5. Ybarra LF, Rinfret S, Brilakis ES. et al. Chronic Total Occlusion Academic Research Consortium. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO‑ARC Consensus Recommendations. Circulation. 2021 Feb 2;143(5):479-500. 6. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59:991-7. 7. Surmely JF, Katoh O, Tsuchikane E, Nasu K, Suzuki T. Coronary septal collaterals as an access for the retrograde approach in the percutaneous treatment of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2007;69:826-32. 8. Colombo A, Mikhail GW, Michev I, et al. Treating chronic total occlusions using subintimal tracking and re‑entry: the STAR technique. Catheter Cardiovasc Interv. 2005;64:407-11. 9. Lombardi WL. Retrograde PCI: what will they think of next. J Invasive Cardiol. 2009;21:543. 10. Werner GS, Schofer J, Sievert H, Kugler C, Reifart NJ. Multicentre experience with the BridgePoint devices to facilitate recanalisation of chronic total coronary occlusions through controlled subintimal re‑entry. EuroIntervention. 2011;7:192-200. 11. Christopoulos G, Karmpaliotis D, Alaswad K, et al. Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015;198:222-8. 12. Råmunddal T, Hoebers LP, Henriques JPS, et al. Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry). JACC Cardiovasc Interv. 2016;9:1535-44. 13. Banning AP, Serruys P, De Maria GL, et al. Five‑year outcomes after state‑of‑the‑art percutaneous coronary revascularization in patients with de novo three‑vessel disease: final results of the SYNTAX II study. Eur Heart J. 2022;43:1307-16. 14. Lawton JS, Tamis‑Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Jan 18;145(3):e4-e17. 15. Neumann FJ, Sousa‑Uva M, Ahlsson A, et al.; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019 Jan 7;40(2):87-165. 16. Di Mario C, Mashayekhi KA, Garbo R, et al. Recanalisation of coronary chronic total occlusions. EuroIntervention. 2022 Sep 20;18(7):535-561. 17. Tsai TT, Stanislawski MA, Shunk KA, et al. Contemporary Incidence, Management, and Long‑Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions: Insights From the VA CART Program. JACC Cardiovasc Interv. 2017 May 8;10(9):866-875. 18. Tajti P, Burke MN, Karmpaliotis D, et al. Prevalence and Outcomes of Percutaneous Coronary Interventions for Ostial Chronic Total Occlusions: Insights From a Multicenter Chronic Total Occlusion Registry. Can J Cardiol. 2018 Oct;34(10):1264-1274. 19. Sapontis J, Salisbury AC, Yeh RW, et al. Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN‑CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures). JACC Cardiovasc Interv. 2017 Aug 14;10(15):1523-1534. 20. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation. 2005 Oct 18;112(16):2530-7. 21. Henriques JP, Hoebers LP, Råmunddal T, et al. EXPLORE Trial Investigators. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. 22. Mashayekhi K, Nührenberg TG, Toma A, et al. A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion: The REVASC Trial. JACC Cardiovasc Interv. 2018 Oct 8;11(19):1982-1991. 23. Lee SW, Lee PH, Ahn JM, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. Circulation. 2019 Apr 2;139(14):1674-1683. 24. Werner GS, Martin‑Yuste V, Hildick‑Smith D, et al.; EUROCTO trial investigators. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018 Jul 7;39(26):2484-2493. 25. Christiansen E. ISCHEMIA‑CTO Trial - Revascularisation or Optimal Medical Therapy of CTO (ISCHEMIA‑CTO). 2018. Available from: https://clinicaltrials.gov/ct2/show/NCT03563417. 26. Minneapolis Heart Institute Foundation. The SHINE‑CTO Trial (SHINE‑CTO). 2016. Available from: https://clinicaltrials. gov/ct2/show/NCT02784418. 27. The NOrdic‑Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion (NOBLE ‑CTO). 2018. Available from: https://clinicaltrials.gov/ct2/ show/NCT03392415. 28. Obedinskiy AA, Kretov EI, Boukhris M, et al. The IMPACTOR‑CTO Trial. JACC Cardiovasc Interv. 2018 Jul 9;11(13):1309-1311. 29. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 Jan 14;41(3):407-477. 30. Brilakis ES, Banerjee S, Karmpaliotis D, et al. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: A report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv 2015;8:245–253. 31. Maeremans J, Walsh S, Knaapen P, et al. The hybrid algorithm for treating chronic total occlusions in Europe: The RECHARGE registry. J Am Coll Cardiol. 2016;68:1958-1970. 32. Galassi AR, Sianos G, Werner GS, et al. Euro CTO Club. Retrograde recanalization of chronic total occlusions in Europe: Procedural, in‑hospital, and long‑term outcomes from the multicenter ERCTO registry. J Am Coll Cardiol. 2015;65:2388-400. 33. Christakopoulos GE, Christopoulos G, Carlino M, et al. Meta‑analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. Am J Cardiol. 2015;115:1367-1375. 34. Mehran R, Claessen BE, Godino C, et al. Multinational Chronic Total Occlusion Registry. Long‑term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv. 2011;4:952-961. 35. Claessen BE, Dangas GD, Godino C, et al. Multinational Cto Registry. Long‑term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. Am J Cardiol. 2011;108:924-931. 36. Jones DA, Weerackody R, Rathod K, et al. Successful recanalization of chronic total occlusions is associated with improved long‑term survival. JACC Cardiovasc Interv 2012;5:380-388. 37. Grantham JA, Jones PG, Cannon L, et al. Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia’s Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial. Circ Cardiovasc Qual Outcomes. 2010;3:284-290. 38. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: A systematic review and meta‑analysis. Am Heart J. 2010;160:179-187. 39. Borgia F, Viceconte N, Ali O, et al. Improved cardiac survival, freedom from MACE and angina‑related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions. Int J Cardiol. 2012;161:31-8. 40. George S, Cockburn J, Clayton TC, et al.; British Cardiovascular Intervention Society; National Institute for Cardiovascular Outcomes Research. Long‑term follow‑up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol. 2014;64:235-43. 41. Goel PK, Khanna R, Pandey C, Ashfaq F. Long‑term outcomes post chronic total occlusion intervention‑implications of completeness of revascularization. J Interv Cardiol. 2018;31:293-301. 42. Tomasello SD, Boukhris M, Giubilato S, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36:3189-98. 43. Park TK, Lee SH, Choi KH, et al. Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow‑Up Study. J Am Heart Assoc. 2021;10:e019022. 44. Juricic SA, Tesic MB, Galassi AR, et al. Randomized Controlled Comparison of Optimal Medical Therapy with Percutaneous Recanalization of Chronic Total Occlusion (COMET‑CTO). Int Heart J. 2021;62:16-22. 45. Brilakis ES, Mashayekhi K, Burke MN. How DECISION‑CTO Can Help Guide the Decision to Perform Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation. 2019 Apr 2;139(14):1684-1687. 46. Galassi AR, Boukhris M, Toma A, et al. Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients With Low Left Ventricular Ejection Fraction. JACC Cardiovasc Interv. 2017;10:2158-70. 47. Werner GS, Surber R, Kuethe F, et al. Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion. Am Heart J. 2005;149:129-37. 48. de Winter RW, Schumacher SP, van Diemen PA, et al. Impact of percutaneous coronary intervention of chronic total occlusions on absolute perfusion in remote myocardium. EuroIntervention. 2022;18:e314-23. 49. Maron DJ, Hochman JS, Reynolds HR, et al. ISCHEMIA Research Group. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382:1395-407. 50. Navarese EP, Lansky AJ, Kereiakes DJ, et al. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta‑analysis. Eur Heart J. 2021;42:4638-51. 51. Al‑Lamee R, Jacobs AK. ISCHEMIA Trial: Was It Worth the Wait? Circulation. 2020;142:517-9. 52. King SB 3rd. The ISCHEMIA Trial: „Stable Angina Cured“. Cardiovasc Revasc Med. 2020;21:254-55. 53. Velazquez EJ, Lee KL, Deja MA, et al. STICH Investigators. Coronary‑artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607-16. 54. Velazquez EJ, Lee KL, Jones RH, et al. STICHES Investigators. Coronary‑Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016;374:1511-20. 55. Fujii T, Sakai K, Nakano M, et al. Impact of the origin of the collateral feeding donor artery on short‑term mortality in ST‑elevation myocardial infarction with comorbid chronic total occlusion. Int J Cardiol. 2016;218:158-63. 56. Kral A, Belohlavek J, Rob D, Smalcova J. Abstract 13434: Chronic Total Occlusions in Refractory Cardiac Arrest Patients. Available from: https://doi.org/10.1161/circ.144.suppl_2.13434. 57. Antman EM, Braunwald E. Managing Stable Ischemic Heart Disease. N Engl J Med. 2020;382:1468-70. 58. Schumacher SP, Stuijfzand WJ, Opolski MP, et al. Per-
RkJQdWJsaXNoZXIy NDA4Mjc=